

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.27689970 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.27689970 |
| 3 | behavioral response to nicotine (GO:0035095) | 5.15056225 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.10034860 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.98273113 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.95148050 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.95148050 |
| 8 | complement activation, alternative pathway (GO:0006957) | 4.82119203 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.78897653 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.78897653 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.78897653 |
| 12 | tryptophan metabolic process (GO:0006568) | 4.57881025 |
| 13 | L-fucose catabolic process (GO:0042355) | 4.51108218 |
| 14 | fucose catabolic process (GO:0019317) | 4.51108218 |
| 15 | L-fucose metabolic process (GO:0042354) | 4.51108218 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.47445792 |
| 17 | protein carboxylation (GO:0018214) | 4.46404902 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.46404902 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.32823481 |
| 20 | regulation of protein activation cascade (GO:2000257) | 4.32707573 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.25191931 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.22628367 |
| 23 | urea cycle (GO:0000050) | 4.20935049 |
| 24 | urea metabolic process (GO:0019627) | 4.20935049 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.20503589 |
| 26 | regulation of complement activation (GO:0030449) | 4.15338672 |
| 27 | homocysteine metabolic process (GO:0050667) | 4.12429587 |
| 28 | plasma lipoprotein particle clearance (GO:0034381) | 4.10914491 |
| 29 | phospholipid efflux (GO:0033700) | 4.03130442 |
| 30 | platelet dense granule organization (GO:0060155) | 4.00470662 |
| 31 | reverse cholesterol transport (GO:0043691) | 3.99714660 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 3.94802378 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 3.90910928 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 3.89020362 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 3.86925875 |
| 36 | macromolecular complex remodeling (GO:0034367) | 3.86925875 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 3.86925875 |
| 38 | regulation of fibrinolysis (GO:0051917) | 3.83163228 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 3.83014594 |
| 40 | response to pheromone (GO:0019236) | 3.82591211 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 3.79275225 |
| 42 | ketone body metabolic process (GO:1902224) | 3.78366108 |
| 43 | bile acid metabolic process (GO:0008206) | 3.72789518 |
| 44 | triglyceride homeostasis (GO:0070328) | 3.71744301 |
| 45 | acylglycerol homeostasis (GO:0055090) | 3.71744301 |
| 46 | low-density lipoprotein particle remodeling (GO:0034374) | 3.70540354 |
| 47 | glyoxylate metabolic process (GO:0046487) | 3.69444544 |
| 48 | tyrosine metabolic process (GO:0006570) | 3.61724419 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 3.56976952 |
| 50 | amine catabolic process (GO:0009310) | 3.54372240 |
| 51 | cellular biogenic amine catabolic process (GO:0042402) | 3.54372240 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.53833660 |
| 53 | negative regulation of mast cell activation (GO:0033004) | 3.53596066 |
| 54 | cholesterol efflux (GO:0033344) | 3.53192340 |
| 55 | phospholipid homeostasis (GO:0055091) | 3.46112377 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 3.45278211 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.44536311 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44536311 |
| 59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44536311 |
| 60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44536311 |
| 61 | modulation by symbiont of host immune response (GO:0052553) | 3.44536311 |
| 62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44536311 |
| 63 | complement activation (GO:0006956) | 3.43030560 |
| 64 | bile acid and bile salt transport (GO:0015721) | 3.35006689 |
| 65 | protein activation cascade (GO:0072376) | 3.29864252 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 3.29398503 |
| 67 | complement activation, classical pathway (GO:0006958) | 3.29118645 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 3.26169328 |
| 69 | negative regulation of lipase activity (GO:0060192) | 3.25197583 |
| 70 | fatty acid beta-oxidation (GO:0006635) | 3.25079028 |
| 71 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.22906885 |
| 72 | cellular response to ATP (GO:0071318) | 3.21541673 |
| 73 | fibrinolysis (GO:0042730) | 3.21438553 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 3.20213292 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.17579505 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.17579505 |
| 77 | lipoprotein metabolic process (GO:0042157) | 3.17075806 |
| 78 | regulation of hippo signaling (GO:0035330) | 3.16893107 |
| 79 | plasma lipoprotein particle organization (GO:0071827) | 3.16269695 |
| 80 | fatty acid oxidation (GO:0019395) | 3.15633137 |
| 81 | lipid oxidation (GO:0034440) | 3.13830507 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 3.12253079 |
| 83 | cysteine metabolic process (GO:0006534) | 3.11896532 |
| 84 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.11349395 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.08687131 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.07009795 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.06337121 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05324193 |
| 89 | negative regulation of cholesterol transport (GO:0032375) | 3.04916006 |
| 90 | negative regulation of sterol transport (GO:0032372) | 3.04916006 |
| 91 | cellular glucuronidation (GO:0052695) | 3.04585753 |
| 92 | fatty acid catabolic process (GO:0009062) | 3.04227456 |
| 93 | positive regulation of defense response to virus by host (GO:0002230) | 3.04095395 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00349774 |
| 95 | S-adenosylmethionine metabolic process (GO:0046500) | 2.98089083 |
| 96 | benzene-containing compound metabolic process (GO:0042537) | 2.96642245 |
| 97 | regulation of cholesterol storage (GO:0010885) | 2.96460106 |
| 98 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.95899196 |
| 99 | detection of light stimulus involved in visual perception (GO:0050908) | 2.95899196 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 2.95885681 |
| 101 | microglial cell activation (GO:0001774) | 2.95310996 |
| 102 | cellular response to exogenous dsRNA (GO:0071360) | 2.95297503 |
| 103 | protein-lipid complex subunit organization (GO:0071825) | 2.95109490 |
| 104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94685199 |
| 105 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.94460224 |
| 106 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.94460224 |
| 107 | drug catabolic process (GO:0042737) | 2.93946886 |
| 108 | lysine metabolic process (GO:0006553) | 2.93885877 |
| 109 | lysine catabolic process (GO:0006554) | 2.93885877 |
| 110 | DNA deamination (GO:0045006) | 2.93020199 |
| 111 | cellular amino acid catabolic process (GO:0009063) | 2.92333324 |
| 112 | exogenous drug catabolic process (GO:0042738) | 2.92064721 |
| 113 | cholesterol homeostasis (GO:0042632) | 2.90581493 |
| 114 | NAD biosynthetic process (GO:0009435) | 2.90257561 |
| 115 | regulation of memory T cell differentiation (GO:0043380) | 2.88900486 |
| 116 | protein-lipid complex assembly (GO:0065005) | 2.88626794 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.88461369 |
| 118 | carnitine metabolic process (GO:0009437) | 2.87497066 |
| 119 | blood coagulation, intrinsic pathway (GO:0007597) | 2.86770042 |
| 120 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.86640750 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.86311690 |
| 122 | cytolysis (GO:0019835) | 2.86130577 |
| 123 | dopamine transport (GO:0015872) | 2.84620008 |
| 124 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.81628487 |
| 125 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.81314430 |
| 126 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.79663910 |
| 127 | mannosylation (GO:0097502) | 2.75843645 |
| 128 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.66640426 |
| 129 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.66640426 |
| 130 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.66567357 |
| 131 | positive regulation of fatty acid transport (GO:2000193) | 2.65690761 |
| 132 | sulfation (GO:0051923) | 2.64137394 |
| 133 | endosome to melanosome transport (GO:0035646) | 2.63674557 |
| 134 | endosome to pigment granule transport (GO:0043485) | 2.63674557 |
| 135 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.61447675 |
| 136 | arginine metabolic process (GO:0006525) | 2.60940862 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 2.59542579 |
| 138 | organic cation transport (GO:0015695) | 2.59332636 |
| 139 | magnesium ion transport (GO:0015693) | 2.58198475 |
| 140 | adaptation of signaling pathway (GO:0023058) | 2.55781923 |
| 141 | negative regulation of telomere maintenance (GO:0032205) | 2.54540296 |
| 142 | basic amino acid transport (GO:0015802) | 2.54384444 |
| 143 | signal peptide processing (GO:0006465) | 2.53740725 |
| 144 | norepinephrine metabolic process (GO:0042415) | 2.49589254 |
| 145 | parturition (GO:0007567) | 2.49392386 |
| 146 | glycerophospholipid catabolic process (GO:0046475) | 2.48955974 |
| 147 | multicellular organism reproduction (GO:0032504) | 2.47033746 |
| 148 | regulation of hexokinase activity (GO:1903299) | 2.45915597 |
| 149 | regulation of glucokinase activity (GO:0033131) | 2.45915597 |
| 150 | fucosylation (GO:0036065) | 2.45660958 |
| 151 | cornea development in camera-type eye (GO:0061303) | 2.44204619 |
| 152 | thyroid hormone metabolic process (GO:0042403) | 2.43020907 |
| 153 | amino acid salvage (GO:0043102) | 2.42898839 |
| 154 | L-methionine salvage (GO:0071267) | 2.42898839 |
| 155 | L-methionine biosynthetic process (GO:0071265) | 2.42898839 |
| 156 | methionine biosynthetic process (GO:0009086) | 2.42428325 |
| 157 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.41669707 |
| 158 | organelle membrane fusion (GO:0090174) | 2.40247020 |
| 159 | cilium morphogenesis (GO:0060271) | 2.38557138 |
| 160 | negative regulation of complement activation (GO:0045916) | 2.38002462 |
| 161 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.37656439 |
| 162 | positive regulation of fatty acid oxidation (GO:0046321) | 2.37385775 |
| 163 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.35418336 |
| 164 | protein-cofactor linkage (GO:0018065) | 2.35257775 |
| 165 | positive regulation of icosanoid secretion (GO:0032305) | 2.33780422 |
| 166 | primary amino compound metabolic process (GO:1901160) | 2.33270445 |
| 167 | phasic smooth muscle contraction (GO:0014821) | 2.33169912 |
| 168 | fucose metabolic process (GO:0006004) | 2.32410512 |
| 169 | positive regulation of heat generation (GO:0031652) | 2.32014318 |
| 170 | oxidative demethylation (GO:0070989) | 2.30107770 |
| 171 | negative regulation of protein autophosphorylation (GO:0031953) | 2.28882554 |
| 172 | rRNA catabolic process (GO:0016075) | 2.28431938 |
| 173 | sphingoid metabolic process (GO:0046519) | 2.27983679 |
| 174 | toxin metabolic process (GO:0009404) | 2.26537543 |
| 175 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.26224805 |
| 176 | macroautophagy (GO:0016236) | 2.24995135 |
| 177 | alkaloid metabolic process (GO:0009820) | 2.24581745 |
| 178 | nucleotide transmembrane transport (GO:1901679) | 2.23977777 |
| 179 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.23687803 |
| 180 | piRNA metabolic process (GO:0034587) | 2.23262294 |
| 181 | response to nitrosative stress (GO:0051409) | 2.23248797 |
| 182 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.22357919 |
| 183 | respiratory chain complex IV assembly (GO:0008535) | 2.22351336 |
| 184 | epithelial cilium movement (GO:0003351) | 2.22122032 |
| 185 | autophagic vacuole fusion (GO:0000046) | 2.21053157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.50729376 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67282115 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.93872260 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.82807473 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74167546 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.16973504 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.74018021 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.66092845 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44735336 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.31446040 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24656635 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09120521 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.04100758 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.75320517 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.72251866 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49550235 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.45368253 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42638536 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41516081 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33177538 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15649319 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15216666 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.13329867 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.02250568 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85419408 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83297948 |
| 27 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77339151 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.75689534 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73033450 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69250509 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.67709221 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66104343 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63060776 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61077665 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58305461 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54508702 |
| 37 | AR_20517297_ChIP-Seq_VCAP_Human | 1.49996928 |
| 38 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.48072922 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45439300 |
| 40 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.45183452 |
| 41 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.43254989 |
| 42 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.43254989 |
| 43 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41703018 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.41053127 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40698061 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39876465 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39041277 |
| 48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36364200 |
| 49 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35207620 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34730668 |
| 51 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.34630527 |
| 52 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34306009 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33107326 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31404280 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31240947 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30521793 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29680215 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29581682 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29368442 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29368442 |
| 61 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28872606 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28554025 |
| 63 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27918969 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27789418 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27752571 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27197780 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26145463 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24079337 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.24023630 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22291837 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20498766 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19669965 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18524635 |
| 74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18318945 |
| 75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17387276 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.16823009 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16626130 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16208811 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16208811 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13910338 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13255466 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13059024 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12881079 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12801157 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12533633 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11801560 |
| 87 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11454853 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11404187 |
| 89 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11294672 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11144889 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09681915 |
| 92 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09524684 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09404830 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09088434 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08378246 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07668839 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07668839 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07508699 |
| 99 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06524184 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06029452 |
| 101 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05970683 |
| 102 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04394039 |
| 103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03994395 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03306586 |
| 105 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03048722 |
| 106 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03048722 |
| 107 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.02500303 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02413691 |
| 109 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.02289264 |
| 110 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01939599 |
| 111 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00651941 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00487755 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00424859 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99952611 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99112064 |
| 116 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98779942 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98552613 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98468254 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98077171 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97538957 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97230789 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96938891 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96798729 |
| 124 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96061650 |
| 125 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95065972 |
| 126 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94213027 |
| 127 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93985732 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93331173 |
| 129 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91044374 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90644054 |
| 131 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.84991149 |
| 132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84844112 |
| 133 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84718383 |
| 134 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.82218721 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81806664 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81424073 |
| 137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81357948 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81103088 |
| 139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80509277 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80379205 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80056950 |
| 142 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79618230 |
| 143 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79130593 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78579017 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78464946 |
| 146 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78384945 |
| 147 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77230341 |
| 148 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76568859 |
| 149 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75340925 |
| 150 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73777952 |
| 151 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73630207 |
| 152 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.73408784 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72993662 |
| 154 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72907290 |
| 155 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72666342 |
| 156 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71518515 |
| 157 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69768797 |
| 158 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.69726227 |
| 159 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69112127 |
| 160 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.68580773 |
| 161 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68381520 |
| 162 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.67837916 |
| 163 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.67551335 |
| 164 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.67036271 |
| 165 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66167742 |
| 166 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.65432430 |
| 167 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.65417526 |
| 168 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65242909 |
| 169 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64955823 |
| 170 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.64948839 |
| 171 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64546752 |
| 172 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.63804680 |
| 173 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63638104 |
| 174 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63133602 |
| 175 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62869044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.80543670 |
| 2 | MP0005360_urolithiasis | 5.25727005 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.56012045 |
| 4 | MP0005365_abnormal_bile_salt | 4.52651833 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.56771452 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.46648315 |
| 7 | MP0009840_abnormal_foam_cell | 3.30686739 |
| 8 | MP0003252_abnormal_bile_duct | 3.21354674 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.10106873 |
| 10 | MP0000427_abnormal_hair_cycle | 2.64339210 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.62227525 |
| 12 | MP0003195_calcinosis | 2.43843160 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.39347922 |
| 14 | MP0003724_increased_susceptibility_to | 2.38565089 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.34642179 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.33502900 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.30958649 |
| 18 | MP0005670_abnormal_white_adipose | 2.21769221 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.14269810 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.08862740 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.96131437 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.94007897 |
| 23 | MP0006082_CNS_inflammation | 1.92889858 |
| 24 | MP0005332_abnormal_amino_acid | 1.91832228 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.90547080 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.87978450 |
| 27 | * MP0000609_abnormal_liver_physiology | 1.86602228 |
| 28 | MP0010386_abnormal_urinary_bladder | 1.72691223 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.71895713 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.71753793 |
| 31 | MP0003646_muscle_fatigue | 1.70609433 |
| 32 | MP0009764_decreased_sensitivity_to | 1.65782258 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.60242420 |
| 34 | MP0003690_abnormal_glial_cell | 1.59650868 |
| 35 | MP0004043_abnormal_pH_regulation | 1.59155546 |
| 36 | MP0001919_abnormal_reproductive_system | 1.57863297 |
| 37 | MP0002102_abnormal_ear_morphology | 1.56743983 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.56514975 |
| 39 | MP0003436_decreased_susceptibility_to | 1.56347077 |
| 40 | MP0006054_spinal_hemorrhage | 1.55298863 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.54964422 |
| 42 | MP0008872_abnormal_physiological_respon | 1.54629062 |
| 43 | MP0004130_abnormal_muscle_cell | 1.52663775 |
| 44 | MP0009697_abnormal_copulation | 1.52249947 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.51767373 |
| 46 | MP0005083_abnormal_biliary_tract | 1.51268579 |
| 47 | MP0002419_abnormal_innate_immunity | 1.51059374 |
| 48 | MP0005389_reproductive_system_phenotype | 1.50449349 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.50239787 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.49544040 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.46672888 |
| 52 | MP0001764_abnormal_homeostasis | 1.44439514 |
| 53 | MP0001542_abnormal_bone_strength | 1.43489806 |
| 54 | MP0003868_abnormal_feces_composition | 1.39429257 |
| 55 | MP0005253_abnormal_eye_physiology | 1.38630913 |
| 56 | MP0004885_abnormal_endolymph | 1.37462701 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37388881 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.36532407 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.36042312 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.34277494 |
| 61 | MP0004142_abnormal_muscle_tone | 1.32727807 |
| 62 | MP0008469_abnormal_protein_level | 1.32465949 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.32301643 |
| 64 | MP0005379_endocrine/exocrine_gland_phen | 1.31852891 |
| 65 | MP0003186_abnormal_redox_activity | 1.31568193 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.31517769 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.30974079 |
| 68 | MP0002736_abnormal_nociception_after | 1.28338423 |
| 69 | MP0005410_abnormal_fertilization | 1.26396862 |
| 70 | MP0005503_abnormal_tendon_morphology | 1.25713813 |
| 71 | MP0000383_abnormal_hair_follicle | 1.23925335 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.22859446 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.21733284 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.18248464 |
| 75 | MP0009763_increased_sensitivity_to | 1.14418428 |
| 76 | MP0005025_abnormal_response_to | 1.13060591 |
| 77 | MP0000343_altered_response_to | 1.12897540 |
| 78 | MP0000013_abnormal_adipose_tissue | 1.07702991 |
| 79 | MP0009785_altered_susceptibility_to | 1.07561087 |
| 80 | MP0000538_abnormal_urinary_bladder | 1.07148382 |
| 81 | MP0003011_delayed_dark_adaptation | 1.06818273 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.06683798 |
| 83 | MP0008877_abnormal_DNA_methylation | 1.06655545 |
| 84 | MP0005334_abnormal_fat_pad | 1.04987792 |
| 85 | MP0002971_abnormal_brown_adipose | 1.04836342 |
| 86 | MP0003075_altered_response_to | 1.02865737 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 1.02391976 |
| 88 | MP0001790_abnormal_immune_system | 1.02066193 |
| 89 | MP0005387_immune_system_phenotype | 1.02066193 |
| 90 | MP0002693_abnormal_pancreas_physiology | 1.00892803 |
| 91 | MP0000372_irregular_coat_pigmentation | 1.00838213 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.99948704 |
| 93 | MP0005647_abnormal_sex_gland | 0.98317131 |
| 94 | MP0000598_abnormal_liver_morphology | 0.97753764 |
| 95 | MP0001853_heart_inflammation | 0.95819280 |
| 96 | MP0004133_heterotaxia | 0.95614013 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.94946776 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.94936198 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.94657690 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.92657735 |
| 101 | MP0005451_abnormal_body_composition | 0.91809577 |
| 102 | MP0003303_peritoneal_inflammation | 0.89884898 |
| 103 | MP0001324_abnormal_eye_pigmentation | 0.89878646 |
| 104 | MP0000604_amyloidosis | 0.89323789 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.88837161 |
| 106 | MP0002160_abnormal_reproductive_system | 0.88644259 |
| 107 | MP0002090_abnormal_vision | 0.87073341 |
| 108 | MP0002938_white_spotting | 0.87021937 |
| 109 | MP0002733_abnormal_thermal_nociception | 0.86672271 |
| 110 | * MP0009642_abnormal_blood_homeostasis | 0.84452590 |
| 111 | MP0002254_reproductive_system_inflammat | 0.84386826 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.83806945 |
| 113 | MP0009046_muscle_twitch | 0.83366082 |
| 114 | MP0005000_abnormal_immune_tolerance | 0.83230340 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.82817046 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.82467795 |
| 117 | MP0009745_abnormal_behavioral_response | 0.82354590 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.82131474 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.81625497 |
| 120 | MP0005535_abnormal_body_temperature | 0.81186274 |
| 121 | MP0001756_abnormal_urination | 0.80637703 |
| 122 | MP0009115_abnormal_fat_cell | 0.79952874 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.78424066 |
| 124 | MP0000249_abnormal_blood_vessel | 0.78293146 |
| 125 | MP0005671_abnormal_response_to | 0.78199288 |
| 126 | MP0005448_abnormal_energy_balance | 0.78129077 |
| 127 | MP0001970_abnormal_pain_threshold | 0.77699129 |
| 128 | MP0005195_abnormal_posterior_eye | 0.76928639 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.76556435 |
| 130 | MP0002168_other_aberrant_phenotype | 0.75172375 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.73352825 |
| 132 | MP0005164_abnormal_response_to | 0.72974615 |
| 133 | MP0002928_abnormal_bile_duct | 0.72806903 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.72573337 |
| 135 | MP0002933_joint_inflammation | 0.72326907 |
| 136 | MP0001800_abnormal_humoral_immune | 0.71802487 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.71799172 |
| 138 | MP0000685_abnormal_immune_system | 0.71305566 |
| 139 | MP0005166_decreased_susceptibility_to | 0.69753007 |
| 140 | MP0010678_abnormal_skin_adnexa | 0.68563655 |
| 141 | MP0004883_abnormal_blood_vessel | 0.68366461 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.68316722 |
| 143 | MP0001879_abnormal_lymphatic_vessel | 0.68278500 |
| 144 | MP0002723_abnormal_immune_serum | 0.67865513 |
| 145 | MP0002295_abnormal_pulmonary_circulatio | 0.66658710 |
| 146 | MP0004510_myositis | 0.66164083 |
| 147 | MP0005636_abnormal_mineral_homeostasis | 0.65850950 |
| 148 | MP0005408_hypopigmentation | 0.64202581 |
| 149 | MP0005595_abnormal_vascular_smooth | 0.62445992 |
| 150 | MP0001661_extended_life_span | 0.62203563 |
| 151 | MP0000371_diluted_coat_color | 0.61976780 |
| 152 | MP0005375_adipose_tissue_phenotype | 0.61363795 |
| 153 | MP0002837_dystrophic_cardiac_calcinosis | 0.60653902 |
| 154 | MP0005376_homeostasis/metabolism_phenot | 0.60340893 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.59184821 |
| 156 | MP0000230_abnormal_systemic_arterial | 0.57639323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 6.06516668 |
| 2 | Abnormality of complement system (HP:0005339) | 5.66692319 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.66106766 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.03566855 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.98587356 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.97182400 |
| 7 | Xanthomatosis (HP:0000991) | 4.88170674 |
| 8 | Joint hemorrhage (HP:0005261) | 4.82201189 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.68397766 |
| 10 | Congenital stationary night blindness (HP:0007642) | 4.58552410 |
| 11 | Pancreatic cysts (HP:0001737) | 4.45911009 |
| 12 | Glomerulonephritis (HP:0000099) | 4.41867257 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.36139213 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.20841718 |
| 15 | Abnormality of midbrain morphology (HP:0002418) | 4.03184842 |
| 16 | Molar tooth sign on MRI (HP:0002419) | 4.03184842 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.82313978 |
| 18 | Myocardial infarction (HP:0001658) | 3.75049084 |
| 19 | Pancreatic fibrosis (HP:0100732) | 3.73627487 |
| 20 | True hermaphroditism (HP:0010459) | 3.66940274 |
| 21 | Tubular atrophy (HP:0000092) | 3.64027311 |
| 22 | Type II lissencephaly (HP:0007260) | 3.63546096 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.60928078 |
| 24 | Nephritis (HP:0000123) | 3.57374742 |
| 25 | Congenital, generalized hypertrichosis (HP:0004540) | 3.53792868 |
| 26 | Abnormality of the renal cortex (HP:0011035) | 3.53769544 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.53394051 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51234170 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.50331246 |
| 30 | Epidermoid cyst (HP:0200040) | 3.45306726 |
| 31 | Nephronophthisis (HP:0000090) | 3.40497015 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.37061096 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.36757129 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 3.36757129 |
| 35 | Hyperalaninemia (HP:0003348) | 3.36757129 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.36445266 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.33613412 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27362219 |
| 39 | Hyperammonemia (HP:0001987) | 3.24885039 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.23636041 |
| 41 | Ketosis (HP:0001946) | 3.22293196 |
| 42 | Hyperglycinuria (HP:0003108) | 3.20031918 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19461449 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.18106811 |
| 45 | Increased corneal curvature (HP:0100692) | 3.17267441 |
| 46 | Keratoconus (HP:0000563) | 3.17267441 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 3.17036595 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 3.08878947 |
| 49 | Abnormality of the renal medulla (HP:0100957) | 3.05980110 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04318403 |
| 51 | Progressive inability to walk (HP:0002505) | 3.03803924 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.03556032 |
| 53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.96450295 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.94210552 |
| 55 | Hyperventilation (HP:0002883) | 2.93912472 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.93799825 |
| 57 | Concave nail (HP:0001598) | 2.93208262 |
| 58 | Attenuation of retinal blood vessels (HP:0007843) | 2.90097399 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.86803141 |
| 60 | Inability to walk (HP:0002540) | 2.85681324 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.85455465 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.85455465 |
| 63 | Hyperglycinemia (HP:0002154) | 2.81408739 |
| 64 | Large for gestational age (HP:0001520) | 2.75254029 |
| 65 | Abnormal drinking behavior (HP:0030082) | 2.74539910 |
| 66 | Polydipsia (HP:0001959) | 2.74539910 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.74017823 |
| 68 | Ketoacidosis (HP:0001993) | 2.72967479 |
| 69 | Cystic liver disease (HP:0006706) | 2.72707845 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71824674 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71824674 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71824674 |
| 73 | Mesangial abnormality (HP:0001966) | 2.70333283 |
| 74 | Fat malabsorption (HP:0002630) | 2.70108642 |
| 75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.67617054 |
| 76 | Abolished electroretinogram (ERG) (HP:0000550) | 2.67457553 |
| 77 | Amyloidosis (HP:0011034) | 2.65612153 |
| 78 | Chronic hepatic failure (HP:0100626) | 2.64122960 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.63398380 |
| 80 | Recurrent abscess formation (HP:0002722) | 2.63161248 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.61444101 |
| 82 | Chorioretinal atrophy (HP:0000533) | 2.59360065 |
| 83 | Mitral stenosis (HP:0001718) | 2.58669959 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.58390370 |
| 85 | Severe muscular hypotonia (HP:0006829) | 2.55947906 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54913094 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54913094 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54913094 |
| 89 | Pendular nystagmus (HP:0012043) | 2.53396733 |
| 90 | Eczematoid dermatitis (HP:0000976) | 2.53273006 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53125135 |
| 92 | Mucopolysacchariduria (HP:0008155) | 2.53125135 |
| 93 | * Cerebral palsy (HP:0100021) | 2.52641367 |
| 94 | Skin nodule (HP:0200036) | 2.49608649 |
| 95 | Gingival bleeding (HP:0000225) | 2.45608327 |
| 96 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.44116107 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 2.39033724 |
| 98 | Axonal loss (HP:0003447) | 2.36525460 |
| 99 | Decreased central vision (HP:0007663) | 2.35266552 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34840950 |
| 101 | Fair hair (HP:0002286) | 2.34219868 |
| 102 | Esophageal varix (HP:0002040) | 2.30105058 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29036799 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 2.29036799 |
| 105 | Renal cortical cysts (HP:0000803) | 2.28180248 |
| 106 | Decreased circulating renin level (HP:0003351) | 2.27032262 |
| 107 | Vascular calcification (HP:0004934) | 2.26582248 |
| 108 | Pancreatitis (HP:0001733) | 2.25790550 |
| 109 | Delayed CNS myelination (HP:0002188) | 2.25359713 |
| 110 | Abnormality of serum amino acid levels (HP:0003112) | 2.24569333 |
| 111 | Disproportionate short-trunk short stature (HP:0003521) | 2.22660617 |
| 112 | Furrowed tongue (HP:0000221) | 2.22060828 |
| 113 | Cerebellar dysplasia (HP:0007033) | 2.19124955 |
| 114 | Stomatitis (HP:0010280) | 2.18699140 |
| 115 | Spontaneous hematomas (HP:0007420) | 2.15659751 |
| 116 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.15551435 |
| 117 | Abnormality of purine metabolism (HP:0004352) | 2.15149016 |
| 118 | Polyuria (HP:0000103) | 2.14639502 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 2.13715100 |
| 120 | Hydroxyprolinuria (HP:0003080) | 2.13715100 |
| 121 | Hemorrhage of the eye (HP:0011885) | 2.12467802 |
| 122 | Hyperbilirubinemia (HP:0002904) | 2.10634802 |
| 123 | Abnormality of the pons (HP:0007361) | 2.10102054 |
| 124 | Loss of speech (HP:0002371) | 2.09178307 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 2.09045830 |
| 126 | Nausea (HP:0002018) | 2.07601078 |
| 127 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.07174495 |
| 128 | Bile duct proliferation (HP:0001408) | 2.06369712 |
| 129 | Abnormal biliary tract physiology (HP:0012439) | 2.06369712 |
| 130 | Generalized hypopigmentation of hair (HP:0011358) | 2.05243484 |
| 131 | Cardiovascular calcification (HP:0011915) | 2.04972062 |
| 132 | Generalized aminoaciduria (HP:0002909) | 2.04824033 |
| 133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03545836 |
| 134 | Hypertriglyceridemia (HP:0002155) | 2.02968736 |
| 135 | Steatorrhea (HP:0002570) | 2.02906011 |
| 136 | Sclerocornea (HP:0000647) | 2.02665112 |
| 137 | Symptomatic seizures (HP:0011145) | 2.02195718 |
| 138 | Thrombophlebitis (HP:0004418) | 2.02184824 |
| 139 | Congenital primary aphakia (HP:0007707) | 2.01727327 |
| 140 | Hypothermia (HP:0002045) | 1.99245248 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 1.98502925 |
| 142 | Gait imbalance (HP:0002141) | 1.98154388 |
| 143 | Lissencephaly (HP:0001339) | 1.98027644 |
| 144 | Clumsiness (HP:0002312) | 1.96968238 |
| 145 | Pulmonary embolism (HP:0002204) | 1.96717691 |
| 146 | Congenital sensorineural hearing impairment (HP:0008527) | 1.95818734 |
| 147 | Tubulointerstitial fibrosis (HP:0005576) | 1.95713854 |
| 148 | Metabolic acidosis (HP:0001942) | 1.95424156 |
| 149 | Hypoalbuminemia (HP:0003073) | 1.90714482 |
| 150 | Abnormal albumin level (HP:0012116) | 1.90714482 |
| 151 | Hypoplasia of the pons (HP:0012110) | 1.88359872 |
| 152 | Pachygyria (HP:0001302) | 1.87843913 |
| 153 | * Hepatocellular carcinoma (HP:0001402) | 1.87754848 |
| 154 | Progressive visual loss (HP:0000529) | 1.87411759 |
| 155 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85724042 |
| 156 | Late onset (HP:0003584) | 1.85656756 |
| 157 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.84727504 |
| 158 | Upper motor neuron abnormality (HP:0002127) | 1.84127937 |
| 159 | Menorrhagia (HP:0000132) | 1.83746328 |
| 160 | Tachypnea (HP:0002789) | 1.83457159 |
| 161 | Methylmalonic acidemia (HP:0002912) | 1.81488278 |
| 162 | Hypochromic microcytic anemia (HP:0004840) | 1.81407001 |
| 163 | Facial diplegia (HP:0001349) | 1.81390078 |
| 164 | Macular degeneration (HP:0000608) | 1.80825339 |
| 165 | Hypoproteinemia (HP:0003075) | 1.80503230 |
| 166 | Adrenal hypoplasia (HP:0000835) | 1.79904551 |
| 167 | Recurrent skin infections (HP:0001581) | 1.78993767 |
| 168 | Abnormality of macrophages (HP:0004311) | 1.78778914 |
| 169 | Orchitis (HP:0100796) | 1.76933826 |
| 170 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76908162 |
| 171 | Retinal atrophy (HP:0001105) | 1.76780247 |
| 172 | Hematochezia (HP:0002573) | 1.75273363 |
| 173 | Conical tooth (HP:0000698) | 1.75117226 |
| 174 | Male pseudohermaphroditism (HP:0000037) | 1.73595879 |
| 175 | Abnormal urine output (HP:0012590) | 1.73490226 |
| 176 | Abnormality of macular pigmentation (HP:0008002) | 1.70288214 |
| 177 | Ovoid vertebral bodies (HP:0003300) | 1.70236747 |
| 178 | Gaze-evoked nystagmus (HP:0000640) | 1.70175834 |
| 179 | Absent speech (HP:0001344) | 1.68224628 |
| 180 | Methylmalonic aciduria (HP:0012120) | 1.67733838 |
| 181 | Widely spaced teeth (HP:0000687) | 1.66683727 |
| 182 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.64461127 |
| 183 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.64443088 |
| 184 | Genetic anticipation (HP:0003743) | 1.63826616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.38337003 |
| 2 | TGFBR2 | 3.09503092 |
| 3 | WNK4 | 3.04594304 |
| 4 | ERN1 | 2.94599073 |
| 5 | BCKDK | 2.92310997 |
| 6 | TAOK3 | 2.84101809 |
| 7 | IRAK3 | 2.75545358 |
| 8 | ACVR1B | 2.68354855 |
| 9 | TIE1 | 2.63727368 |
| 10 | BMPR1B | 2.50381745 |
| 11 | TYK2 | 2.47407323 |
| 12 | IRAK4 | 2.45079383 |
| 13 | TLK1 | 2.37463931 |
| 14 | FGFR4 | 2.37067633 |
| 15 | MAP4K2 | 2.25773491 |
| 16 | BLK | 2.20762390 |
| 17 | MAP3K14 | 2.15429095 |
| 18 | CAMK1D | 1.97323044 |
| 19 | TBK1 | 1.93936196 |
| 20 | JAK1 | 1.91107592 |
| 21 | ADRBK1 | 1.89272252 |
| 22 | MAPKAPK3 | 1.88266088 |
| 23 | NEK9 | 1.86157026 |
| 24 | SIK1 | 1.77731289 |
| 25 | OXSR1 | 1.72949807 |
| 26 | MAPK15 | 1.72695421 |
| 27 | TAOK2 | 1.63795220 |
| 28 | STK39 | 1.59967213 |
| 29 | FRK | 1.58501205 |
| 30 | KDR | 1.54787595 |
| 31 | CSF1R | 1.54703822 |
| 32 | GRK1 | 1.53354271 |
| 33 | FER | 1.53108397 |
| 34 | CSK | 1.50424741 |
| 35 | FGFR3 | 1.47325363 |
| 36 | MST4 | 1.47122922 |
| 37 | KIT | 1.40626632 |
| 38 | MAP2K3 | 1.36464497 |
| 39 | MAP4K1 | 1.36389083 |
| 40 | PRKAA2 | 1.32312828 |
| 41 | IKBKE | 1.28532030 |
| 42 | WNK3 | 1.27114269 |
| 43 | ZAK | 1.26687374 |
| 44 | PIK3CG | 1.26304949 |
| 45 | NUAK1 | 1.25610675 |
| 46 | CAMK1G | 1.23111839 |
| 47 | TEC | 1.21535837 |
| 48 | EPHB1 | 1.21288177 |
| 49 | TXK | 1.19457284 |
| 50 | LIMK1 | 1.19302074 |
| 51 | MAP3K3 | 1.17547003 |
| 52 | TGFBR1 | 1.16758201 |
| 53 | GRK7 | 1.16743357 |
| 54 | PAK3 | 1.11180413 |
| 55 | JAK3 | 1.07306020 |
| 56 | JAK2 | 1.07212732 |
| 57 | IKBKB | 1.07155195 |
| 58 | MET | 1.06998035 |
| 59 | MAPK11 | 1.05393313 |
| 60 | PTK2B | 1.04481002 |
| 61 | MST1R | 1.02175478 |
| 62 | FLT3 | 1.01634323 |
| 63 | BRSK2 | 1.01415307 |
| 64 | IRAK1 | 0.97626154 |
| 65 | PTK6 | 0.95468874 |
| 66 | PHKG1 | 0.92351697 |
| 67 | PHKG2 | 0.92351697 |
| 68 | PINK1 | 0.92158427 |
| 69 | MAPK13 | 0.91960434 |
| 70 | MKNK2 | 0.90426490 |
| 71 | PIK3CA | 0.89713535 |
| 72 | SGK2 | 0.87578506 |
| 73 | EPHA3 | 0.85811104 |
| 74 | ITK | 0.84987686 |
| 75 | PRKCG | 0.82918274 |
| 76 | TRIB3 | 0.82781969 |
| 77 | ZAP70 | 0.80017147 |
| 78 | MYLK | 0.78806317 |
| 79 | PRKCI | 0.78720126 |
| 80 | PKN1 | 0.77989802 |
| 81 | SGK3 | 0.76017513 |
| 82 | LYN | 0.73117498 |
| 83 | MAPKAPK5 | 0.72894347 |
| 84 | ERBB4 | 0.70905878 |
| 85 | ERBB3 | 0.70828309 |
| 86 | HCK | 0.70274492 |
| 87 | IGF1R | 0.68946790 |
| 88 | CDK9 | 0.68351988 |
| 89 | MAP3K5 | 0.67591494 |
| 90 | MAPK12 | 0.66191646 |
| 91 | MAP3K6 | 0.64624679 |
| 92 | MAPK7 | 0.64326550 |
| 93 | BTK | 0.62560916 |
| 94 | GRK5 | 0.62345298 |
| 95 | EIF2AK2 | 0.62192013 |
| 96 | PDPK1 | 0.62163996 |
| 97 | IRAK2 | 0.58539694 |
| 98 | SYK | 0.57797405 |
| 99 | FES | 0.57020196 |
| 100 | EPHB2 | 0.56927681 |
| 101 | ABL2 | 0.56212126 |
| 102 | AKT3 | 0.55709997 |
| 103 | RIPK1 | 0.53304231 |
| 104 | MAP2K1 | 0.52701531 |
| 105 | CAMKK2 | 0.51478652 |
| 106 | CDK6 | 0.50947298 |
| 107 | PRKAA1 | 0.50625960 |
| 108 | ABL1 | 0.49504099 |
| 109 | ADRBK2 | 0.49400544 |
| 110 | PRKCD | 0.48916872 |
| 111 | PRKACG | 0.48886144 |
| 112 | DYRK2 | 0.48822006 |
| 113 | GSK3A | 0.47042240 |
| 114 | DAPK2 | 0.45090712 |
| 115 | BMPR2 | 0.44811144 |
| 116 | MAPK4 | 0.44656256 |
| 117 | PDK1 | 0.44652741 |
| 118 | CHUK | 0.44548534 |
| 119 | CAMK4 | 0.44188462 |
| 120 | TRIM28 | 0.42666339 |
| 121 | TNK2 | 0.42437206 |
| 122 | LCK | 0.41922599 |
| 123 | STK38L | 0.41902349 |
| 124 | MAP2K6 | 0.41197744 |
| 125 | SIK2 | 0.41124126 |
| 126 | CAMK2A | 0.40838878 |
| 127 | WNK1 | 0.40457815 |
| 128 | SGK223 | 0.40282318 |
| 129 | SGK494 | 0.40282318 |
| 130 | YES1 | 0.40193737 |
| 131 | TRPM7 | 0.39945180 |
| 132 | EPHA2 | 0.39768648 |
| 133 | PRKCQ | 0.39761849 |
| 134 | CSNK1A1 | 0.38454601 |
| 135 | PRKCE | 0.37366539 |
| 136 | ERBB2 | 0.36694205 |
| 137 | CAMK1 | 0.35964708 |
| 138 | STK3 | 0.35576826 |
| 139 | MAP2K4 | 0.35146151 |
| 140 | MAP2K2 | 0.34245335 |
| 141 | CSNK1G3 | 0.34221082 |
| 142 | PNCK | 0.33349503 |
| 143 | PRKCA | 0.33326150 |
| 144 | RPS6KA5 | 0.32581557 |
| 145 | OBSCN | 0.31877247 |
| 146 | PRKG1 | 0.31578958 |
| 147 | PRKACA | 0.31048563 |
| 148 | CSNK1G1 | 0.30382294 |
| 149 | EIF2AK3 | 0.29583670 |
| 150 | CASK | 0.28834549 |
| 151 | CAMK2D | 0.28424366 |
| 152 | PRKD2 | 0.27612426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93964589 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.28909543 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.26443431 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76385437 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.64286174 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58689080 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58556525 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56252858 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38201886 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30245046 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.28738283 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27083632 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.25571720 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21355469 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.15432119 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10586993 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97071391 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93804914 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93504324 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92295823 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89957814 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87686543 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81063848 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.78746901 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77191045 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71336087 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.69451792 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.68568874 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68206104 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.63047462 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61622655 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59532646 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.58315786 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.56420358 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54867123 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47520374 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45070739 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42879254 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.42678359 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40248420 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40106636 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39610378 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32760842 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30518508 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.29275931 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.26292300 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25045470 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.24559134 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23945896 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17814658 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 1.15361029 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12156284 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09628843 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.08674550 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06181688 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04646269 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03111539 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99142003 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99082153 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92523975 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89532533 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88560351 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.87357955 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85023542 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.82175224 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78902856 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78221850 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75249049 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73047237 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71304594 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.70988907 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70965297 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70286289 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69811164 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.68826342 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67959629 |
| 77 | Morphine addiction_Homo sapiens_hsa05032 | 0.65753961 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65265507 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61480040 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60621593 |
| 81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59819405 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58606696 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.58065938 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57744488 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55768585 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54490152 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53677153 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.52856293 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52685018 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.50600877 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.49213015 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49207159 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45585418 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45548102 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43252543 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.42836729 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.42605368 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41555154 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41511080 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41458278 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40372288 |
| 102 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40279280 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.39955174 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.39542932 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38710655 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36960668 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36455816 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36298446 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35447402 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35398231 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34692187 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34331771 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33885810 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33269192 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31496804 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.30412567 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.30295670 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.29899904 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29449504 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29231556 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28152734 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28033706 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.27836912 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.26565930 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25563679 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25553602 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.25270365 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25053928 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20986382 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20633100 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19399834 |
| 132 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18621238 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14862561 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13950657 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13394911 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12791052 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.08081897 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.06444905 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06307964 |

